tiprankstipranks
Advertisement
Advertisement

DSGN Stock Latest News

Design Therapeutics management to meet with Oppenheimer
The FlyDesign Therapeutics management to meet with Oppenheimer
6h ago
DSGN
Design Therapeutics reports Q2 EPS (32c), consensus (34c)
PremiumThe Fly
Design Therapeutics reports Q2 EPS (32c), consensus (34c)
1M ago
DSGN
Citizens biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens biotech analysts hold an analyst/industry conference call
2M ago
BIIB
DSGN
Design Therapeutics initiates patient dosing in DT-818 trial
PremiumThe Fly
Design Therapeutics initiates patient dosing in DT-818 trial
2M ago
DSGN
Design Therapeutics Stockholders Approve Director and Auditor at Meeting
PremiumCompany Announcements
Design Therapeutics Stockholders Approve Director and Auditor at Meeting
3M ago
8K
DSGN
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe FlyActing FDA head vows to block political interference, Endpoint News says
3M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
3M ago
AZN
BMY
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
Premium
The Fly
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
4M ago
D
F
Design Therapeutics reports positive Phase 1/2 DT-216P2 data
PremiumCompany Announcements
Design Therapeutics reports positive Phase 1/2 DT-216P2 data
4M ago
8K
DSGN
Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial
PremiumThe Fly
Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial
4M ago
DSGN
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
4M ago
AZN
BMY
Design Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Design Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
DSGN
Design Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDesign Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
DSGN
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
4M ago
DYN
RNA
Design Therapeutics price target raised to $21 from $18 at Oppenheimer
Premium
The Fly
Design Therapeutics price target raised to $21 from $18 at Oppenheimer
4M ago
DSGN
Design Therapeutics price target raised to $20 from $12 at Piper Sandler
PremiumThe Fly
Design Therapeutics price target raised to $20 from $12 at Piper Sandler
4M ago
DSGN
Design Therapeutics reports Q1 EPS (29c), consensus (33c)
PremiumThe Fly
Design Therapeutics reports Q1 EPS (29c), consensus (33c)
4M ago
DSGN
Design Therapeutics Reports Q1 2026 Results and Pipeline Progress
PremiumCompany Announcements
Design Therapeutics Reports Q1 2026 Results and Pipeline Progress
4M ago
8K
DSGN
Design Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Design Therapeutics management to meet with Oppenheimer
5M ago
DSGN
Design Therapeutics management to meet with Oppenheimer
PremiumThe FlyDesign Therapeutics management to meet with Oppenheimer
5M ago
DSGN
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
5M ago
DYN
RNA
Design Therapeutics management to meet with Oppenheimer
Premium
The Fly
Design Therapeutics management to meet with Oppenheimer
5M ago
DSGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >